Comments to FDA: Self-Selection Studies for Nonprescription Drug Products Share page: Docket Number: FDA-2011-D-0620-0001 Enclosed herein are comments on "Guidance for Industry: Self-Selection Studies for Nonprescription Drug Products." Download Document Issues: OTC Medicines Rx-to-OTC Switch Other Issues Research Related Posts Press Releases and Statements CHPA Applauds White House Executive Order Prioritizing Lower Drug Costs and Access to Self-Care Apr 17, 2025 Press Releases and Statements CHPA Responds to Section 232 Investigation on Pharmaceuticals Apr 15, 2025 Press Releases and Statements CHPA Commends Lawmakers for Urging FDA to Protect the Rx-OTC-Switch Pathway Apr 11, 2025